SI1326592T1 - Uporaba polietilenglikola (peg) za pripravo zdravila za zdravljenje obstipacije (zapeke) - Google Patents

Uporaba polietilenglikola (peg) za pripravo zdravila za zdravljenje obstipacije (zapeke)

Info

Publication number
SI1326592T1
SI1326592T1 SI200130868T SI200130868T SI1326592T1 SI 1326592 T1 SI1326592 T1 SI 1326592T1 SI 200130868 T SI200130868 T SI 200130868T SI 200130868 T SI200130868 T SI 200130868T SI 1326592 T1 SI1326592 T1 SI 1326592T1
Authority
SI
Slovenia
Prior art keywords
peg
polyethylene glycol
constipation
medicament
manufacture
Prior art date
Application number
SI200130868T
Other languages
English (en)
Inventor
Mark Vb Cleveland
Russell W Pelham
Original Assignee
Braintree Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braintree Lab filed Critical Braintree Lab
Publication of SI1326592T1 publication Critical patent/SI1326592T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrotherapy Devices (AREA)
SI200130868T 2000-09-28 2001-09-27 Uporaba polietilenglikola (peg) za pripravo zdravila za zdravljenje obstipacije (zapeke) SI1326592T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/675,105 US6645481B1 (en) 2000-09-28 2000-09-28 Method of achieving overnight laxation and control of bowel function
EP01975466A EP1326592B1 (en) 2000-09-28 2001-09-27 Use of polyethylene glycol ( peg ) for the manufacture of a medicament for the treatment of constipation
PCT/US2001/030227 WO2002026222A2 (en) 2000-09-28 2001-09-27 Method of achieving overnight laxation and control of bowel function

Publications (1)

Publication Number Publication Date
SI1326592T1 true SI1326592T1 (sl) 2009-02-28

Family

ID=24709076

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130868T SI1326592T1 (sl) 2000-09-28 2001-09-27 Uporaba polietilenglikola (peg) za pripravo zdravila za zdravljenje obstipacije (zapeke)

Country Status (12)

Country Link
US (1) US6645481B1 (sl)
EP (1) EP1326592B1 (sl)
AT (1) ATE401900T1 (sl)
AU (1) AU2001294790A1 (sl)
CA (1) CA2423746A1 (sl)
CY (1) CY1110052T1 (sl)
DE (1) DE60135001D1 (sl)
DK (1) DK1326592T3 (sl)
ES (1) ES2310190T3 (sl)
PT (1) PT1326592E (sl)
SI (1) SI1326592T1 (sl)
WO (1) WO2002026222A2 (sl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291324B2 (en) * 2002-10-22 2007-11-06 Braintree Laboratories Inc. Method of bowel cleansing
US20060029570A1 (en) * 2003-11-17 2006-02-09 Braintree Laboratories, Inc. Therapeutic PEG solution concentrate
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
US7256202B2 (en) * 2003-12-31 2007-08-14 Halow George M Composition and method for treatment of hepatic encephalopathy
US20050244368A1 (en) * 2004-04-29 2005-11-03 Pashankar Dinesh S Pre-endoscopic use of polyethylene glycol compositions
US20060247180A1 (en) * 2005-04-29 2006-11-02 Bergey James L Purgative composition and uses thereof
WO2006118562A1 (en) * 2005-04-29 2006-11-09 Inkine Pharmaceutical Company, Inc. Purgative composition and uses thereof
US7495063B2 (en) * 2006-02-03 2009-02-24 Dow Global Technologies Inc. Reduced oligomer concentration in high purity polyalkylene glycols
MX2015012109A (es) 2013-03-15 2016-04-15 Braintree Lab Composicion farmaceutica oral de sales sulfato para comprimidos de uso dual y metodos para su uso.
KR20170007303A (ko) 2014-04-29 2017-01-18 코로나리콘셉츠 엘엘씨 전해질 대체를 제공하기 위한 식품, 시스템, 방법 및 키트
US10067103B2 (en) 2015-03-02 2018-09-04 Colonaryconcepts Llc Compounds and methods for PEG metabolite and PEG breakdown product assays

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710183A (en) 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
US6048901A (en) * 1999-04-20 2000-04-11 Braintree Laboratories, Inc. Method of reducing intestinal gas, cramping and anorectal irritation

Also Published As

Publication number Publication date
WO2002026222A8 (en) 2002-06-27
ES2310190T3 (es) 2009-01-01
CA2423746A1 (en) 2002-04-04
WO2002026222A2 (en) 2002-04-04
DE60135001D1 (de) 2008-09-04
DK1326592T3 (da) 2008-11-10
US6645481B1 (en) 2003-11-11
AU2001294790A1 (en) 2002-04-08
EP1326592B1 (en) 2008-07-23
ATE401900T1 (de) 2008-08-15
EP1326592A1 (en) 2003-07-16
CY1110052T1 (el) 2015-01-14
PT1326592E (pt) 2008-10-20

Similar Documents

Publication Publication Date Title
CY1110052T1 (el) Η χρηση της πολυαιθυλενογλυκολης (peg) για την κατασκευη φαρμακου για τη θεραπεια της δυσκοιλιοτητας
MY129356A (en) Electrospun pharmaceutical compositions
MXPA03005893A (es) Proteccion, restauracion, y mejora de celulas, tejidos y organos que responden a la eritropoyetina.
MXPA01007411A (es) Composiciones y metodos para suministro mucoso.
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
WO2002048141A1 (en) Medicinal compositions improved in solublity in water
IL116083A (en) Liquid pharmaceutical compositions containing ondanseteron and sorbitol as sweetener
NZ501950A (en) Medicinal compositions for application to mucosa
EP1048297A3 (en) Use of polyethylene glycol for reducing of intestinal gas, cramping and anorectal irritation
AU2001292119A1 (en) Absorption enhancers
WO2002026191A3 (en) Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
PL346764A1 (en) New oral formulation for 5-ht4
EP1354602A4 (en) MEDICAL COMPOSITIONS WITH DIURETIC AGENT AND IMPROVING INSULIN RESISTANCE
YU28002A (sh) Farmaceutska kompozicija koja sadrži ciklesonid za primenu na sluzokoži
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
BR0008952A (pt) Composição de preparação de iodo
SE9902597D0 (sv) New use
YU13599A (sh) Primena farmaceutske kompozicije za dobijanje leka u obliku gela
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
MD1473G2 (ro) Remediu antiherpetic
IL129267A (en) Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence
WO2002036105A3 (en) Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
WO2001091733A3 (de) Wirkstoffkombination enthaltend montirelin und eine verbindung mit opioider wirksamkeit
SE9802119D0 (sv) New use